NEW YORK (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $2.5 million in its fiscal first quarter.

On a per-share basis, the New York-based company said it had a loss of 15 cents.

The drug maker posted revenue of $674,000 in the period.

Oramed shares have risen nearly 7% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.50, an increase of 59% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP

Automated Insights, source Associated Press News